Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Arvinas Inc (ARVN)

Arvinas Inc (ARVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Arvinas Inc 5 SCIENCE PARK 395 WINCHESTER AVENUE NEW HAVEN CT 06511 USA

www.arvinas.com Employees: 430 P: 203-535-1456

Sector:

Medical

Description:

Arvinas Inc. is a biopharmaceutical company for patients suffering from debilitating and life-threatening diseases. It engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Arvinas Inc. is based in CT, United States.

Key Statistics

Overview:

Market Capitalization, $K 772,615
Enterprise Value, $K 672,715
Shares Outstanding, K 64,224
Float, K 61,186
% Float 95.27%
Short Interest, K 4,859
Short Float 7.57%
Days to Cover 6.20
Short Volume Ratio 0.51
% of Insider Shareholders 4.73%
% of Institutional Shareholders 95.19%

Financials:

Annual Sales, $ 263,400 K
Annual Net Income, $ -198,900 K
Last Quarter Sales, $ 41,900 K
Last Quarter Net Income, $ -35,100 K
EBIT, $ -102,000 K
EBITDA, $ -112,600 K

Growth:

1-Year Return -32.15%
3-Year Return -60.33%
5-Year Return -83.30%
5-Year Revenue Growth 512.84%
5-Year Earnings Growth -30.05%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.48 on 11/05/25
Next Earnings Date 02/10/26 [--]
Earnings Per Share ttm -0.81
EPS Growth vs. Prev Qtr 42.86%
EPS Growth vs. Prev Year 29.41%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ARVN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -9.77%
Return-on-Assets % -6.08%
Profit Margin % -75.51%
Debt/Equity 0.00
Price/Sales 2.93
Price/Cash Flow N/A
Price/Book 1.59
Book Value/Share 7.69
Interest Coverage -0.20
60-Month Beta 1.89
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar